BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20029375)

  • 1. FAAH deficiency promotes energy storage and enhances the motivation for food.
    Touriño C; Oveisi F; Lockney J; Piomelli D; Maldonado R
    Int J Obes (Lond); 2010 Mar; 34(3):557-68. PubMed ID: 20029375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance.
    Balsevich G; Sticht M; Bowles NP; Singh A; Lee TTY; Li Z; Chelikani PK; Lee FS; Borgland SL; Hillard CJ; McEwen BS; Hill MN
    Proc Natl Acad Sci U S A; 2018 Jul; 115(29):7605-7610. PubMed ID: 29967158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task.
    Wise LE; Harloe JP; Lichtman AH
    Neurobiol Learn Mem; 2009 Nov; 92(4):597-601. PubMed ID: 19524055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
    Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
    Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
    Schlosburg JE; Kinsey SG; Lichtman AH
    AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
    Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endocannabinoids and their analogues in obesity and eating disorders.
    Gaetani S; Kaye WH; Cuomo V; Piomelli D
    Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice.
    Newberry EP; Kennedy SM; Xie Y; Luo J; Crooke RM; Graham MJ; Fu J; Piomelli D; Davidson NO
    J Lipid Res; 2012 Apr; 53(4):744-54. PubMed ID: 22327204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM; Vann RE; Wiley JL
    Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice.
    Cassano T; Gaetani S; Macheda T; Laconca L; Romano A; Morgese MG; Cimmino CS; Chiarotti F; Bambico FR; Gobbi G; Cuomo V; Piomelli D
    Psychopharmacology (Berl); 2011 Mar; 214(2):465-76. PubMed ID: 21042794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
    Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
    Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
    J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
    Clapper JR; Moreno-Sanz G; Russo R; Guijarro A; Vacondio F; Duranti A; Tontini A; Sanchini S; Sciolino NR; Spradley JM; Hohmann AG; Calignano A; Mor M; Tarzia G; Piomelli D
    Nat Neurosci; 2010 Oct; 13(10):1265-70. PubMed ID: 20852626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide.
    Osei-Hyiaman D; Depetrillo M; Harvey-White J; Bannon AW; Cravatt BF; Kuhar MJ; Mackie K; Palkovits M; Kunos G
    Neuroendocrinology; 2005; 81(4):273-82. PubMed ID: 16131814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
    Wise LE; Cannavacciulo R; Cravatt BF; Martin BF; Lichtman AH
    Neuropharmacology; 2008 Jan; 54(1):181-8. PubMed ID: 17675189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.